CD8A and neoplasm: Central to this system is the co-localization and co-delivery of diverse tumor antigens, including tumor-associated antigens, mutation-derived neoantigens, and mRNA-encoded antigens, with immunostimulants, a design that leverages the unique properties of each antigen to amplify cross-presentation, the linchpin of CD8+ T cell-mediated cytotoxicity [32].